Biotechnology News

RELEVANCE | TIME
#

Obama Will Continue Genetic and Biotech Relationship For Financial Gains

6 hrs ago | therebel.org

One of Obama’s endeavors is to empower the genetic and biotech industry with the support of embryotic stem cell research. In May, Obama announced that the pharmaceutical corporations and US government were combining forces to...

Read more...

Biotech’s next big disaster: seeds that emit multiple pesticides

23 hrs ago | banoosh.com

Contributed by Jon Rappoport of No More Fake News. Tom Laskawy, writing at Grist, points out how the next generation of GMOs is following in the track of present disasters: “…the growing pest and weed problems for GMOs have...

Read more...
#

Will ASCO Unlock Big Value in This Cancer Drug Class?

3 hrs ago | fool.com

Watch stocks you care about The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... There's little denying that Roche's (NASDAQOTH:...

Read more... All similar articles: 77 »

4th World Congress on Biotechnology

11 hrs ago | myprgenie.com

Los Angeles, California -- May 18, 2013 / ( http://www.myprgenie.com ) -- OMICS Publishing Group seeks to organize the 4th Global Meet on Biotechnology , during September 23-25, 2013, at Raleigh-North Carolina, USA. In the...

Read more...
#

Federal Reserve Chairman Ben S. Bernanke At Bard College At Simon's Rock, Great Barrington,...

2 hrs ago | exchange-handbook.co.uk

Let me start by congratulating the graduates and their parents. The word "graduate" comes from the Latin word for "step." Graduation from college is only one step on a journey, but it is an important one and well worth...

Read more...
#

Here's Why Amgen Shares Are Worth $117 To $126 Today

16 hrs ago | seekingalpha.com

May 18 2013, 01:03 by: Stephen Barnes | about: AMGN Amgen shares (up over 22% year-to-date) have had an impressive run this year, outpacing the S&P 500 by about 6%. Nevertheless, despite outpacing the broader market, Amgen has...

Read more...
#

NIH: Results of the ROTAVAC Rotavirus Vaccine Study in India

16 hrs ago | salutedomani.com

Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health We congratulate the Program for Appropriate Technology in Health (PATH), Bharat Biotech...

Read more...
#

3 Horrendous Health-Care Stocks This Week

9 hrs ago | fool.com

Don't let it get away! Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today. There's one drawback to having the stock market indexes hit record highs yet again: It...

Read more...
#

What’s Moving These Biotech Stocks?

4 hrs ago | fool.com

Brian is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited. As one of the most important conferences in biotechnology approaches (ASCO) we are seeing...

Read more...

Cobra Biologics to manufacture DNA vaccine for Vaccibody

23 hrs ago | bioportfolio.com

Clinical and commercialscale biologics and pharmaceuticals manufacturer Cobra Biologics Ltd and Vaccibody AS a biotechnology company developing nextgeneration vaccines against cancer and chronic infections have formed an...

Read more...
#

SS Eastland Disaster, Monsanto and Self Serving Politicians- Stevan Neill

22 hrs ago | misebogland.wordpress.com

“Government is instituted for the common good; for the protection, safety, prosperity, and happiness of the people; and not for profit, honor, or private interest of any one man, family, or class of men; therefore, the people...

Read more... All similar articles: 243 »
#

New IVF method uses timelapse snapshots to boost live births

16 hrs ago | bioportfolio.com

Related Biotechnology, Pharmaceutical and Healthcare News Searches Linking to this Story Latest Biotechnology, Pharmaceutical and Healthcare News This site complies with the HONcode standard for trustworthy health information:...

Read more... All similar articles: 85 »

Beware of stem cell therapy claims: Column

May 17, 2013 | investorstemcell.com

Alex Berezow, USATODAY3:44 p.m. EDT May 15, 2013 Fortunately, the FDA is starting to crack down. While it can’t control some companies that move outside the country to operate. In the U.S., every medical treatment should be...

Read more...

Two Biotech Ideas You May Have Missed: William Gregozeski

May 16, 2013 | trefis.com

Submitted by The Life Sciences Report as part of our contributors program. This interview was conducted by George S. Mack of The Life Sciences Report (5/16/13) Adventurous investors have long sought out micro-cap stocks,...

Read more...
#

Computer-Designed Proteins to Disarm a Variety of Flu Viruses

May 17, 2013 | anl.gov

Proteins that are found in nature, but do not normally bind the influenza virus, can be engineered to act as broad-spectrum antiviral agents against a variety of flu virus strains, including the H1N1 pandemic influenza,...

Read more...
#

Transgene Announces its Invesment in ElsaLys Biotech, a New Antibody Company Created by Former...

May 17, 2013 | finanzen.net

Transgene zu myNews hinzufügen Was ist das? Regulatory News: Transgene SA (Euronext Paris: TNG)(Paris:TNG), a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer...

Read more...
#

Financings of the Fortnight Waits For Public Investors To Hop On Bluebird

May 17, 2013 | invivoblog.blogspot.cz

It’s been another IPO-intensive couple of weeks here at FOTF HQ. We keep looking for other things to write about, but sometimes the fastest shave on deadline is with Occam’s razor. Or something like that. We didn't exactly ace...

Read more...

Stem cells are the new snake oil

May 17, 2013 | guampdn.com

Angelina Jolie courageously announced Tuesday that she underwent a preventative double mastectomy after genetic testing showed she had a high probability of developing breast and ovarian cancer, which she followed up with...

Read more...
#

Deals Of The Week Is Keeping Score – Valeant Wants Actavis, Which Covets Warner Chilcott …

May 17, 2013 | invivoblog.blogspot.cz

Whether the pastime is baseball, Broadway or the daytime soaps, the old adage is that you can’t keep track of the players without a scorecard. The M&A front involving specialty pharma and generic drug makers has become...

Read more...
#

Mesothelioma Law Firm Baron and Budd Awaits CRS-207 Verdict: New...

May 17, 2013 | prweb.com

Promising Study of CRS-207 Immunotherapy Hopes to Achieve Mesothelioma Remission. Dallas, TX (PRWEB) May 15, 2013 The Mesothelioma Research Foundation of America has announced Aduro BioTech’s initiation of Phase II human trials...

Read more...
#

Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies...

May 17, 2013 | generalholding.co

SAN JOSE, Calif. , May 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased to announce that an agreement has been reached with Switzerland -based Kenta Biotech to acquire Kenta's entire portfolio of anti-infective human...

Read more...
#

A*STAR and Cytos Bring Singapore’s First Influenza Vaccine to Clinical Testing

May 17, 2013 | bizdaily.com.sg

Singapore and Schlieren (Zurich), Switzerland (5/17) – Scanning electron micrograph of Cytos’ Virus-like particle (VLP) used in Singapore’s first H1N1 influenza vaccine. VLPs resemble viruses; they mimic the structure of real...

Read more... All similar articles: 67 »

The IVF industry - "human manufacturing on an industrial scale"

May 17, 2013 | estatevaults.com

IVF may have brought joy – but it’s also brought misery and ended lives With Sir Robert Edwards’s death we should still remember that ‘playing God’ brings problems 'I wish IVF had never been invented' It's brought joy to...

Read more...

Enzymes and Coenzymes: Scientists map elusive 3-D structure of telomerase enzyme, key actor in...

May 17, 2013 | newsrx.com

By a News Reporter-Staff News Editor at Cancer Weekly -- Like finally seeing all the gears of a watch and how they work together, researchers from UCLA and UC Berkeley have, for the first time ever, solved the puzzle of how the...

Read more...

The best is yet to come for Washington’s biotech industry

May 16, 2013 | tri-cityherald.com

Search for Deals Search local inventory, coupons and more The best is yet to come for Washington’s biotech industry 3 hours ago With 70 Washington cities already home to 480 life sciences companies, our state’s role in...

Read more...

Ultragenyx Advances Clinical Development of UX003 for the Treatment of Mucopolysaccharidosis Type...

May 17, 2013 | checkorphan.org

Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, announced a Phase 1/2 study of UX003 for mucopolysaccharidosis type 7 (MPS 7, or Sly Syndrome)....

Read more...

GOVERNOR RICK PERRY: WHY TEXAS WORKS….SEE NOTE PLEASE

May 17, 2013 | ruthfullyyours.com

By Ruth King on May 17th, 2013 http://frontpagemag.com/2013/frontpagemag-com/gov-rick-perry-why-texas-works/ HE IS MY FAVORITE GOVERNOR….NOT A GOOD CANDIDATE OR DEBATER ….BUT AFTER BASHING HIM IN THE PRIMARIES, ALL THE OTHERS...

Read more...
#

Horse, Pig and Rat Meat Adulteration Now Easy to Detect with Simple 1-Hour Visual Field Test

May 17, 2013 | finance.yahoo.com

SAN ANTONIO, MAY 17, 2013 /PRNewswire-iReach/ -- San Antonio, Texas, USA-based Biotech Company Alpha Diagnostic Int'l (ADI) has developed and released a 1-hour horse, pig and rat meat adulteration/contamination ...

Read more...

May 17-EDO

May 17, 2013 | chimeraresearchgroup.com

It seemed to be a quite day as I think everyone is recovering from the ASCO abstract dump. 1. I had some good discussion with people about the PGNX abstract that I posted yesterday and wanted to go into a little more detail....

Read more...

East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More

May 17, 2013 | xconomy.com

All eyes in the biotech world will soon turn to the American Society of Clinical Oncology’s annual meeting in Chicago, but for now, the industry keeps humming along. This week’s news was highlighted by partnerships, product...

Read more...